Novanta Inc Total Liabilities
Novanta Inc total liabilities. Based on the latest financial reports, Novanta Inc (1GSN) has total liabilities worth €704.34 Million EUR (≈ $823.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Novanta Inc to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Novanta Inc (2015–2024)
Total liabilities of Novanta Inc from 2015 to 2024. This chart illustrates how Novanta Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Novanta Inc (1GSN) long-term investment share to see how much of total assets are deployed in long-term investments.
Novanta Inc Competitors by Total Liabilities
The table below lists competitors of Novanta Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wintime Energy Co Ltd
SHG:600157
|
China | CN¥56.37 Billion |
|
KONINKLIJKE VOP.UNSP.ADR
F:VPK
|
Germany | €3.54 Billion |
|
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
|
India | Rs11.91 Billion |
|
MYR Group Inc
NASDAQ:MYRG
|
USA | $970.61 Million |
|
Brookfield Renewable Corp
NYSE:BEPC
|
USA | $41.92 Billion |
|
Fujian Funeng Co Ltd
SHG:600483
|
China | CN¥23.99 Billion |
|
Turkcell Iletisim Hizmetleri AS ORD
IS:TCELL
|
Turkey | TL248.39 Billion |
|
Oklo Inc.
NYSE:OKLO
|
USA | $84.33 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Novanta Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 1GSN current and non-current assets.
Liquidity & Leverage Metrics
Novanta Inc Total Liabilities Ratios Explained
Novanta Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Novanta Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Novanta Inc (2015–2024)
The table below shows the annual total liabilities of Novanta Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €642.81 Million ≈ $751.52 Million |
+16.33% |
| 2023-12-31 | €552.60 Million ≈ $646.04 Million |
-16.73% |
| 2022-12-31 | €663.63 Million ≈ $775.85 Million |
-6.08% |
| 2021-12-31 | €706.59 Million ≈ $826.08 Million |
+81.94% |
| 2020-12-31 | €388.37 Million ≈ $454.05 Million |
-14.18% |
| 2019-12-31 | €452.56 Million ≈ $529.09 Million |
+28.82% |
| 2018-12-31 | €351.32 Million ≈ $410.73 Million |
-15.38% |
| 2017-12-31 | €415.16 Million ≈ $485.36 Million |
+148.94% |
| 2016-12-31 | €166.77 Million ≈ $194.97 Million |
-2.67% |
| 2015-12-31 | €171.34 Million ≈ $200.32 Million |
-- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets las… Read more